. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Fluorescent In Situ Hybridization (FISH) Probe Development to Detect Immunoglobulin Light Chains Kapa (IGK) and Lambda (IGL) Translocations

Reference #:

2005-072

Inventors/Contributors

Ellen D. Remstein M.D., Richard R. Einerson

Description

Lymphoma, the cancer to the lymph glands and lymphocytes develop as a consequence of acquired genetic/chromosomal changes. In clinical practice identification of these genetic changes are critical in diagnosis and treatment of lymphoma patient. We have developed fluorescent in situ hybridization (FISH) for two targets frequently involved in lymphoma development. We believe that these probes will improve diagnosis of lymphoma as well as lead to identification of new genetic alterations important in lymphoma development.

Patent Status

Pending

Contact

Barbara A. Gamez Sims, Licensing Manager
gamezsims.barbara@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 284-8171
Fax: (507) 284-5410